Methylergonovine - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:57:55Z

Switch SMW query from broadtable to table format for better layout with TOC

← Older revision		Revision as of 21:57, 20 March 2026
Line 72:		Line 72:
	\|?Has Route=Route		\|?Has Route=Route
	\|?Has Population=Population		\|?Has Population=Population
	\|format=~~broadtable~~		\|format=table
	\|headers=plain		\|headers=plain
	\|mainlabel=-		\|mainlabel=-

Danbot: Add Indications by Condition SMW query table

2026-03-20T17:45:55Z

Add Indications by Condition SMW query table

← Older revision		Revision as of 17:45, 20 March 2026
Line 61:		Line 61:
	==Comments==		==Comments==



			==Indications by Condition==
			''The following table is automatically generated from disease/condition pages across WikEM.''

			{{#ask:[[Has DrugName::Methylergonovine]]
			\|?Has Indication=Indication
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|?Has Route=Route
			\|?Has Population=Population
			\|format=broadtable
			\|headers=plain
			\|mainlabel=-
			\|sort=Has Indication
			\|limit=50
			}}

	==See Also==		==See Also==

ClaireLewis: /* References */

2019-09-22T23:22:29Z

References

← Older revision		Revision as of 23:22, 22 September 2019
Line 69:		Line 69:

	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:OBGYN]]

Jonwarren: Creation of page

2019-03-06T06:18:17Z

Creation of page

New page

==Administration==
*Type: [[Uterotonic]]
*Dosage Forms: Tablet, injection
*Routes of Administration: IM, IV
*Common Trade Names: Methergine

==Adult Dosing==
===[[Postpartum hemorrhage]]===
*0.2 mg IV q2-4h prn

==Pediatric Dosing==
*Pediatric dosing not applicable or safety has not been established in pediatric patients.

==Special Populations==
===[[Drug pregnancy categories|Pregnancy Rating]]===
*Contraindicated during pregnancy
*No known risk of teratogenicity
*Risk of fetal hypoxia based on mechanism of action

===Lactation risk===
*Avoid breastfeeding during treatment and 12 hours after discontinuing
*Risk for infant vomiting, diarrhea, bradycardia, tachycardia, and seizures

===Renal Dosing===
*Adult: Caution advised in impairment
*Pediatric: N/A

===Hepatic Dosing===
*Adult: Caution advised in impairment
*Pediatric: N/A

==Contraindications==
*Allergy to class/drug
*Intra or periarterial administration
*Pregnancy
*Breastfeeding up to 12 hours after d/c
*[[HTN]]
*Toxemia

==Adverse Reactions==
===Serious===
*[[Seizure]]
*[[HTN]], [[MI]], [[vasospasm]], arterial spasm
*[[Arrhythmia]], [[AV block]]
*[[Thrombophlebitis]]
*[[Stroke]]
*Hallucinations

===Common===
*[[HTN]]
*[[Headache]], [[abdominal pain]], [[nausea]], [[vomiting]]

==Pharmacology==
*Half-life: 3.4h
*Metabolism: Liver
*Excretion: Urine (<5% unchanged), feces

==Mechanism of Action==
*Increases uterine contraction force and frequency

==Comments==

==See Also==
*[[Postpartum hemorrhage]]

==References==
<references/>

[[Category:Pharmacology]]